R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

June 30, 2012

Conditions
Chronic Lymphocytic LeukaemiaPatients Resistant to a Purine AnalogousPatients Relapsed With Purines Therapy
Interventions
DRUG

Rituximab-CHOP-Alemtuzumab

Four Rituximab - CHOP courses will be given The courses will be given every 21 days

Trial Locations (32)

17007

ICO Gerona, Girona

18014

Hospital Virgen de las Nieves, Granada

25198

Hospital Arnau de Vilanova, Lleida

28006

Hospital La Princesa, Madrid

28007

Hospital Gregorio Marañon, Madrid

28033

M.D.Anderson Internacional, Madrid

28034

Hospital Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

28041

Hospital 12 de octubre, Madrid

30008

Hospital Morales Meseguer, Murcia

36680

Hospital Clinico Universitario de Santiago, Santiago de Compostela

37007

Hospital Clinico de Salamanca, Salamanca

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

39008

Hospital Marques de Valdecilla, Santander

41013

Hospital Virgen del Rocio, Seville

43005

Hospital Joan XXIII, Tarragona

46009

Hospital La Fe, Valencia

46011

Hospital Clinico de Valencia, Valencia

46017

Hospital Doctor Peset, Valencia

46018

Hospital General de Valencia, Valencia

46700

Hospital Francisco de Borja, Gandia

48013

Hospital de Basurto, Bilbao

50009

Hospital Miguel Servet, Zaragoza

07014

Hospital de Son Dureta, Palma de Mallorca

08916

ICO Badalona, Badalona

08003

Hospital del Mar, Barcelona

08025

Hospital Santa Creu i Sant Pau, Barcelona

08035

Hospital Valle de Hebron, Barcelona

08907

ICO Bellvitge, L'Hospitalet de Llobregat

08243

Althaia, Manresa

08208

Corporacion Sanitaria Parc Tauli, Sabadell

08036

Hospital Clinic i Provincial., Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Francesc Bosch, MD

UNKNOWN

collaborator

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

OTHER

collaborator

Fundacion Clinic per a la Recerca Biomédica

OTHER

collaborator

Bayer

INDUSTRY

collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

CABYC

INDUSTRY